Our portfolio company Sable Bio has just published a piece about their journey tackling one of healthcare's most critical challenges: making drug development safer and more efficient through augmented intelligence. 30% of clinical trials fail due to unforeseen toxicity, and Alex de Giorgio and Josh Almond-Thynne are making great progress transforming drug safety assessment. 2025 is going to be a huge year!
Episode 1 Ventures’ Post
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development